Ometon (Omeprazole Sodium)

Omeprazole sodium, the active ingredient in Ometon, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Ometon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ometon is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the disorder. - Helicobacter pylori eradication regimens (as part of combination therapy): enhances eradication success by suppressing acid. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer formation in patients requiring long‑term NSAID therapy.

Adverse reactions to Ometon are generally dose‑related and may vary in frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools without blood. - Nausea: occasional feeling of queasiness. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Severe hypomagnesemia: low serum magnesium causing muscle cramps or cardiac arrhythmia. - Acute interstitial nephritis: renal inflammation with possible reduced kidney function. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: extensive skin blistering and detachment. - Hepatic injury: elevated liver enzymes or jaundice. - Anaphylaxis: rapid onset of airway swelling, hypotension and rash.

When prescribing Ometon, clinicians should consider several safety aspects: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor magnesium levels: prolonged therapy can lower serum magnesium. - Evaluate for infection risk: prolonged acid suppression may increase susceptibility to gastrointestinal infections. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole sodium can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular event risk. - Atazanavir and other protease inhibitors: markedly decreased antiviral exposure. - Warfarin: enhanced anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely): - Digoxin: modest increase in serum concentration. - Methotrexate: reduced renal clearance may raise toxicity risk. - Phenytoin: altered metabolism leading to variable plasma levels.